← Back to Discover
Kynam Capital Management, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,809,410,222
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $198,065,407
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $175,993,964
- VAXCYTE INC · COM · 92243G108 · shares: $169,875,334
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $141,916,654
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $124,012,432
- VIRIDIAN THERAPEUTICS INC · COM · 92790C104 · shares: $118,557,720
- TRAVERE THERAPEUTICS INC · COM · 89422G107 · shares: $113,620,000
- BEAM THERAPEUTICS INC · COM · 07373V105 · shares: $97,495,981
- UROGEN PHARMA LTD · COM · M96088105 · shares: $89,578,818
- LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 · shares: $86,674,800
Reported holdings
32 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 5,322,908 shares | $198,065,407 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 8,050,959 shares | $175,993,964 |
| VAXCYTE INC | COM | 92243G108 | — | 2,922,335 shares | $169,875,334 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 3,667,097 shares | $141,916,654 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 2,890,059 shares | $124,012,432 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 6,453,877 shares | $118,557,720 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 2,000,000 shares | $113,620,000 |
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 2,840,792 shares | $97,495,981 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 2,434,207 shares | $89,578,818 |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | — | 3,001,205 shares | $86,674,800 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 21,703,093 shares | $81,386,599 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 3,300,000 shares | $61,743,000 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 3,114,132 shares | $56,708,344 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 934,799 shares | $51,600,905 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 1,375,000 shares | $43,656,250 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 1,194,757 shares | $28,984,805 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 872,558 shares | $28,968,926 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 2,522,660 shares | $25,226,600 |
| PHARVARIS N V | COM | N69605108 | — | 661,795 shares | $22,884,871 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 1,200,000 shares | $17,484,000 |
| PRELUDE THERAPEUTICS INC | COM | 74065P101 | — | 2,415,087 shares | $12,872,414 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 100,000 shares | $10,662,000 |
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L206 | — | 1,238,563 shares | $10,517,747 |
| GERON CORP | COM | 374163103 | — | 6,836,318 shares | $8,750,487 |
| AMARIN CORP PLC | SPONSORED ADR | 023111404 | — | 532,982 shares | $8,495,733 |
| ALECTOR INC | COM | 014442107 | — | 3,808,494 shares | $7,655,073 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 250,000 shares | $6,842,500 |
| CARIBOU BIOSCIENCES INC | COM | 142038108 | — | 2,503,302 shares | $4,405,812 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 1,566,317 shares | $2,913,350 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 96,741 shares | $996,432 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 457,855 shares | $792,089 |
| TRAWS PHARMA INC | COM NEW | 68232V884 | — | 84,400 shares | $71,175 |